Recent developments in 8-aminoquinoline antimalarials.
D000249:Adenosine Monophosphate / Q000378:metabolism; D000596:Amino Acids / Q000378:metabolism; D000634:Aminoquinolines / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D055598:Chemical Phenomena; D002621:Chemistry; D004247:DNA / Q000096:biosynthesis; D006801:Humans; D007700:Kinetics; D050356:Lipid Metabolism; D008928:Mitochondria / Q000378:metabolism; D010452:Peptide Biosynthesis; D010743:Phospholipids / Q000378:metabolism; D010766:Phosphorylation; D012313:RNA / Q000096:biosynthesis; D012343:RNA, Transfer / Q000378:metabolism; D013329:Structure-Activity Relationship
D000596:Amino Acids; D000634:Aminoquinolines; D000962:Antimalarials; D010743:Phospholipids; D000249:Adenosine Monophosphate; D012313:RNA; D004247:DNA; D012343:RNA, Transfer